Rituxirel RN 500 mg Injection
436,77$
340,68$
Rituxirel RN 500 mg Injection is a targeted monoclonal antibody therapy designed to combat various immune system-related disorders. Primarily, it is utilized in the treatment of specific types of cancer, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia, making it an essential option in oncological care. By binding to the CD20 protein on the surface of B cells, Rituxirel effectively depletes these cells, which are often involved in the pathogenesis of these malignancies. Patients receiving this treatment should be aware of potential side effects such as infusion-related reactions and the risk of infections, necessitating close monitoring by healthcare professionals. It's crucial to inform your physician of any pre-existing conditions or medications, as these factors can influence treatment outcomes. Rituxirel offers a valuable avenue for managing challenging diseases, contributing to improved patient prognosis and quality of life. Always consult your healthcare provider for personalized advice and guidance regarding Rituxirel and its role in your treatment plan.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Rituxirel rn 500 mg injection is commonly used in the treatment of non-Hodgkin lymphoma (NHL). This medication targets specific cells in the immune system, helping to reduce the proliferation of malignant cells. By doing so, it aids in managing the symptoms associated with this type of cancer. Patients receiving Rituxirel rn 500 mg injection may experience improved outcomes during their treatment journey.
• Another significant application of Rituxirel rn 500 mg injection is in the management of rheumatoid arthritis. This medication works by modulating the immune response, which can help alleviate joint inflammation and pain. It is typically used in patients who have not responded adequately to other therapies. The use of Rituxirel rn 500 mg injection can lead to enhanced mobility and quality of life for those affected by this chronic condition.
• Rituxirel rn 500 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia (CLL). In this context, the medication targets the malignant B-cells, which play a key role in the progression of the disease. By effectively reducing the number of these cells, Rituxirel rn 500 mg injection can help stabilize the disease and prolong patient survival. Its application in CLL has become an essential part of comprehensive cancer care.
• Additionally, Rituxirel rn 500 mg injection is utilized in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune conditions characterized by inflammation of blood vessels. The medication helps to suppress the abnormal immune response, reducing symptoms and preventing further organ damage. Patients receiving Rituxirel rn 500 mg injection for these conditions often report significant improvements in their health and well-being.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Rituxirel RN 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Rituxirel RN 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Rituxirel RN 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Rituxirel RN 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Rituxirel RN 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Rituxirel RN 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Rituxirel RN 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Rituxirel RN 500 mg. Please consult your doctor.
• Kidney: Rituxirel RN 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Rituxirel RN 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Rituxirel RN 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Rituxirel RN 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Rituxirel RN 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.